-- 中国株は火曜日、米イラン和平協議が世界のエネルギーショックに及ぼす影響を投資家が警戒する中、小幅上昇した。 中国株の主要指標である上海総合指数は2.95ポイント上昇し、4,085.08となった。深セン成分指数は0.1%(15.39ポイント)上昇し、14,982.14となった。 米イラン間の停戦は水曜日に期限切れとなる予定で、ドナルド・トランプ大統領がイラン紛争終結への期待を打ち砕いたにもかかわらず、パキスタンはワシントンとテヘラン間の新たな協議に向けて準備を進めていると、AP通信が火曜日に別途報じた。 一方、中国国内では、いくつかの好材料が見られることから、中国株は年末にかけて5~10%上昇すると見込まれていると、ロイター通信が火曜日にモルガン・スタンレーのアナリストの見解を引用して別途報じた。 しかし、ロイター通信はアナリストの見解を引用し、中東情勢、第1四半期決算発表、そしてトランプ大統領と中国の習近平国家主席の会談への期待感などから、市場のボラティリティは依然として高いと報じた。 企業ニュースでは、深セン証券取引所に初上場した杭州富恩(SHE:001312)が初日の取引で66%高で引けた。この中国の繊維製品メーカーの株価は、取引開始直後に98.6%高で取引を開始した。 上海証券取引所に上場しているSJセミコンダクター(SHA:688820)は、終値で289%急騰した。この半導体ウェハーメーカーの株価は、火曜日の取引開始時に407%高で取引を開始した。
Related Articles
Marvell Technology, Astera Labs to Benefit From Stronger Long-Term Demand Linked to Amazon-Anthropic Deal, RBC Says
Marvell Technology (MRVL) and Astera Labs (ALAB) could benefit from stronger long-term demand tied to Amazon's (AMZN) expanded deal with Anthropic, though near-term gains may be capped by tight 3-nanometer wafer supply, RBC Capital Markets said in a note Tuesday.Marvell remains well placed because it supplies Trainium chips, Ethernet switches, data processing units, and optical digital signal processors to Amazon Web Services, and demand from optical connectivity and Trainium programs is expected to support strong growth through fiscal 2028 and beyond, the investment firm said.RBC said it left its Marvell estimates unchanged for now because supply limits could hold back near-term upside, but it sees added potential from future Trainium4 demand and Marvell's expanding artificial intelligence networking products.For Astera Labs, RBC said Scorpio X switches should begin ramping in volume for Trainium3 racks in Q3, which could help lift revenue in H2 and later periods, and added that Astera also has longer-term growth room at AWS through its UALink and NVLink Fusion-related products, while wins with other large cloud customers add support to its outlook.RBC said the deal gives it more confidence in its 2027 forecasts and longer-term growth view for both companies, and it kept its outperform ratings while raising its price target on Marvell to $170 from $115 and on Astera Labs to $250 from $225.Price: $151.74, Change: $+3.90, Percent Change: +2.64%
Starbucks Q2 Sales, Earnings Upside Seen on Improving US Trends, UBS Says
Starbucks' (SBUX) upcoming fiscal Q2 results are expected to show progress on initiatives to support its accelerating sales trends, with likely upside to sales, margins and earnings, UBS Securities said in a Tuesday note.The company is scheduled to report its Q2 results on April 28.UBS said it now expects Q2 North America same-store sales of 6%, up from 4% previously, compared with the consensus of 4%, and forecasts ticket growth of 1% and transaction growth of 5%.The brokerage said sales are improving with traction against strategic plans including menu innovation, new bakery lineup, continued benefits from the Green Apron Service and operational improvements, adding that it expects North America same-store sales of 5% in fiscal Q3 and 4.7% in fiscal 2026.Additionally, the investment firm said it is modeling adjusted operating margins of 8.6% for fiscal Q2, versus the consensus of 8.3%, aided by easing inflation, lapping investments and cost savings plans. For fiscal 2026, UBS expects operating margins of 10.6%.UBS has a neutral rating on the company's stock with a $100 price target.Price: $97.35, Change: $-1.60, Percent Change: -1.62%
Churchill Capital IX, PlusAI Business Merger Plan Cancelled
Churchill Capital IX (CCIX) and PlusAI terminated their planned business combination, citing market conditions, PlusAI said in a Tuesday statement.PlusAI continues to showcase considerable commercial momentum and remains positioned for long-term growth, according to a statement.Price: $10.74, Change: $+0.02, Percent Change: +0.17%